M.D. Sass Concentrated Value ETF
M.D. Sass Concentrated Value ETF
Your view on SASS
Overview
What the company does, where it operates, and who runs it.
About M.D. Sass Concentrated Value ETF
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- 314 Magnolia Avenue, Fairhope, BE, US
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- 314 Magnolia Avenue, Fairhope, BE, US
SASS seeks long-term capital appreciation by investing in US-listed large- and mid-cap value stocks. The actively managed fund targets undervalued or misunderstood companies with strong fundamentals, financial quality, and forecastable earnings, especially those undergoing positive changes or special situations. The adviser conducts intensive, bottoms-up research that reviews SEC filings, earnings calls, third-party research, industry insights, financial models, and valuations to identify stocks with a differentiated view versus market consensus, favorable reward/risk ratios, and attractive multi-year returns. Investments are assessed with probability-weighted returns and qualitative scores to optimize sizing and minimize bias. The fund believes a well-understood concentrated portfolio provides greater risk-adjusted returns. It holds up to 25 stocks, capping individual positions at 8%, and conducts an analysis of every stock sold to assess performance and inform future improvements.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for M.D. Sass Concentrated Value ETF, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for M.D. Sass Concentrated Value ETF. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for M.D. Sass Concentrated Value ETF. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for M.D. Sass Concentrated Value ETF. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for M.D. Sass Concentrated Value ETF. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
M.D. Sass Concentrated Value ETF valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold M.D. Sass Concentrated Value ETF, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by M.D. Sass Concentrated Value ETF executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming M.D. Sass Concentrated Value ETF. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming M.D. Sass Concentrated Value ETF. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for M.D. Sass Concentrated Value ETF. Press releases and market coverage, newest first.